Association Between Vitamin D Receptor (VDR) Polymorphisms and the Risk of Multiple Sclerosis (MS): an Updated Meta-analysis

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2019 Dec 28

PMID 31878897

Citations 21

Authors

Danyal Imani

Bahman Razi

Morteza Motallebnezhad

Ramazan Rezaei

Affiliations

Soon will be listed here.

Abstract

Background: The association between the Vitamin D Receptor (VDR) gene polymorphism and the risk of Multiple sclerosis (MS) has been evaluated in several researches. However, the findings were inconsistent and inconclusive. Therefore, we set out a meta-analysis of all eligible published case-control studies to obtain an exact evaluation of the association between VDR gene polymorphisms and MS.

Method: All relevant studies reporting the association between the VDR gene FokI (rs2228570), or/and TaqI (rs731236) or/and BsmI (rs1544410) or/and ApaI (rs7975232) polymorphisms and susceptibility to MS published up to May, 2019 were identified by comprehensive systematic search in the electronic database of web of science, Scopus, and PubMed. After that, the strength of association between VDR gene polymorphisms and susceptibility to MS was evaluated by odds ratio (OR) and 95% confidence interval (CI).

Results: A total of 30 case-control studies were included in the meta-analysis. The overall results suggested a significant association between TaqI polymorphism and MS risk under heterozygote genetic model (OR = 1.27, 95%CI = 1.01-1.59, random effect). Moreover, the pooled results of subgroup analysis declined presence of significant association under all defined genetic model. In subgroup analysis, BsmI polymorphisms was associated with increased risk of MS under recessive model in Asian populations. On the other hand, ApaI polymorphism was associated with decreased risk of MS under recessive and aa vs. AA model in Asian populations.

Conclusion: This meta-analysis suggested a significant association between TaqI polymorphism and MS susceptibility. Furthermore, BsmI polymorphism was associated with increased risk of MS in Asian populations. In contrast, ApaI polymorphism was associated with decreased risk of MS in Asian populations. Future large-scale studies on gene-environment and gene-gene interactions are required to estimate risk factors and assist early diagnosis of patients at high risk for MS.

Citing Articles

Association between vitamin D receptor gene polymorphism and essential hypertension: An updated systematic review, meta-analysis, and meta-regression.

Dakota I, Addai M, Maulana R, Ivan I, Sukmawan R, Widyantoro B PLoS One. 2024; 19(12):e0314886.

PMID: 39715198 PMC: 11666036. DOI: 10.1371/journal.pone.0314886.

and Variants of Vitamin D Receptor Gene Associated with Metabolic Syndrome Among Jordanian Women.

Atoum M Oman Med J. 2024; 39(1):e591.

PMID: 38721008 PMC: 11077276. DOI: 10.5001/omj.2024.47.

Vitamin D receptor gene BsmI (rs1544410) polymorphism: role in multiple sclerosis and genotype-phenotype correlations.

Jamoussi M, Alaya F, Jamoussi H, Baraket G, Achouri A, Mahmoud M Mol Biol Rep. 2024; 51(1):478.

PMID: 38578462 DOI: 10.1007/s11033-024-09369-w.

Vitamin D Receptor Gene Polymorphism Predicts the Outcome of Multidisciplinary Rehabilitation in Multiple Sclerosis Patients.

Guerini F, Agliardi C, Oreni L, Groppo E, Bolognesi E, Zanzottera M Int J Mol Sci. 2023; 24(17).

PMID: 37686183 PMC: 10487750. DOI: 10.3390/ijms241713379.

Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review.

Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A Front Immunol. 2023; 14:950465.

PMID: 37520529 PMC: 10379649. DOI: 10.3389/fimmu.2023.950465.

References

Yamout B, Karaky N, Mahfouz R, Jaber F, Estaitieh N, Shamaa D . Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study. J Neuroimmunol. 2016; 293:59-64. DOI: 10.1016/j.jneuroim.2016.02.008. View

Krieger S, Cook K, De Nino S, Fletcher M . The topographical model of multiple sclerosis: A dynamic visualization of disease course. Neurol Neuroimmunol Neuroinflamm. 2016; 3(5):e279. PMC: 5015541. DOI: 10.1212/NXI.0000000000000279. View

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Makoui M, Imani D, Motallebnezhad M, Azimi M, Razi B . Vitamin D receptor gene polymorphism and susceptibility to asthma: Meta-analysis based on 17 case-control studies. Ann Allergy Asthma Immunol. 2019; 124(1):57-69. DOI: 10.1016/j.anai.2019.10.014. View

Pierrot-Deseilligny C, Souberbielle J . Vitamin D and multiple sclerosis: An update. Mult Scler Relat Disord. 2017; 14:35-45. DOI: 10.1016/j.msard.2017.03.014. View

Simon K, Munger K, Yang X, Ascherio A . Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler. 2009; 16(2):133-8. PMC: 2819633. DOI: 10.1177/1352458509355069. View

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

10.

OGorman C, Lucas R, Taylor B . Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci. 2012; 13(9):11718-11752. PMC: 3472772. DOI: 10.3390/ijms130911718. View

11.

Zhang Y, Zhang L, Chen S, Yang G, Huang X, Duan Y . Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studies. Neurol Sci. 2017; 39(2):225-234. DOI: 10.1007/s10072-017-3175-3. View

12.

Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A . Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population. Biomed Res Int. 2015; 2015:427519. PMC: 4320885. DOI: 10.1155/2015/427519. View

13.

Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A, Salimi S . Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in South Eastern of Iran. J Mol Neurosci. 2015; 56(3):572-6. DOI: 10.1007/s12031-015-0513-x. View

14.

Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K . Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci. 2000; 177(1):65-71. DOI: 10.1016/s0022-510x(00)00336-1. View

15.

Moran-Auth Y, Penna-Martinez M, Badenhoop K . VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients. J Steroid Biochem Mol Biol. 2015; 148:184-6. DOI: 10.1016/j.jsbmb.2015.01.003. View

16.

Huang J, Xie Z . Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies. J Neurol Sci. 2011; 313(1-2):79-85. DOI: 10.1016/j.jns.2011.09.024. View

17.

Deluca H . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S. DOI: 10.1093/ajcn/80.6.1689S. View

18.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

19.

Bettencourt A, Boleixa D, Guimaraes A, Leal B, Carvalho C, Bras S . The vitamin D receptor gene FokI polymorphism and Multiple Sclerosis in a Northern Portuguese population. J Neuroimmunol. 2017; 309:34-37. DOI: 10.1016/j.jneuroim.2017.05.005. View

20.

Saccone D, Asani F, Bornman L . Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene. 2015; 561(2):171-80. DOI: 10.1016/j.gene.2015.02.024. View